A case of hypereosinophilia with digital ischaemia successfully treated with intravenous prostaglandin E(1)

In the therapeutic management of eosinophilic disorder, it is important to prevent hypereosinophilia (HE)‐related organ damage even in the process of diagnosis. We describe here a unique clinical and histopathological findings of the patient with HE accompanied with digital ischaemia. Treatment with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaga, M., Takeuchi, H., Iwahara, K., Ihara, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060027/
https://www.ncbi.nlm.nih.gov/pubmed/35664976
http://dx.doi.org/10.1002/ski2.32
_version_ 1784698431462178816
author Kaga, M.
Takeuchi, H.
Iwahara, K.
Ihara, H.
author_facet Kaga, M.
Takeuchi, H.
Iwahara, K.
Ihara, H.
author_sort Kaga, M.
collection PubMed
description In the therapeutic management of eosinophilic disorder, it is important to prevent hypereosinophilia (HE)‐related organ damage even in the process of diagnosis. We describe here a unique clinical and histopathological findings of the patient with HE accompanied with digital ischaemia. Treatment with intravenous prostaglandin E(1) was essential for digital ischaemia in our case while benralizumab, humanized monoclonal antibody against interleukin‐5 receptorα, did not affect. Our case suggests an earlier intervention for digital ischaemia in the therapeutic management of eosiniphilic disorder.
format Online
Article
Text
id pubmed-9060027
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90600272022-06-04 A case of hypereosinophilia with digital ischaemia successfully treated with intravenous prostaglandin E(1) Kaga, M. Takeuchi, H. Iwahara, K. Ihara, H. Skin Health Dis Case Reports In the therapeutic management of eosinophilic disorder, it is important to prevent hypereosinophilia (HE)‐related organ damage even in the process of diagnosis. We describe here a unique clinical and histopathological findings of the patient with HE accompanied with digital ischaemia. Treatment with intravenous prostaglandin E(1) was essential for digital ischaemia in our case while benralizumab, humanized monoclonal antibody against interleukin‐5 receptorα, did not affect. Our case suggests an earlier intervention for digital ischaemia in the therapeutic management of eosiniphilic disorder. John Wiley and Sons Inc. 2021-05-03 /pmc/articles/PMC9060027/ /pubmed/35664976 http://dx.doi.org/10.1002/ski2.32 Text en © 2021 The Authors. Skin Health and Disease published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Kaga, M.
Takeuchi, H.
Iwahara, K.
Ihara, H.
A case of hypereosinophilia with digital ischaemia successfully treated with intravenous prostaglandin E(1)
title A case of hypereosinophilia with digital ischaemia successfully treated with intravenous prostaglandin E(1)
title_full A case of hypereosinophilia with digital ischaemia successfully treated with intravenous prostaglandin E(1)
title_fullStr A case of hypereosinophilia with digital ischaemia successfully treated with intravenous prostaglandin E(1)
title_full_unstemmed A case of hypereosinophilia with digital ischaemia successfully treated with intravenous prostaglandin E(1)
title_short A case of hypereosinophilia with digital ischaemia successfully treated with intravenous prostaglandin E(1)
title_sort case of hypereosinophilia with digital ischaemia successfully treated with intravenous prostaglandin e(1)
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060027/
https://www.ncbi.nlm.nih.gov/pubmed/35664976
http://dx.doi.org/10.1002/ski2.32
work_keys_str_mv AT kagam acaseofhypereosinophiliawithdigitalischaemiasuccessfullytreatedwithintravenousprostaglandine1
AT takeuchih acaseofhypereosinophiliawithdigitalischaemiasuccessfullytreatedwithintravenousprostaglandine1
AT iwaharak acaseofhypereosinophiliawithdigitalischaemiasuccessfullytreatedwithintravenousprostaglandine1
AT iharah acaseofhypereosinophiliawithdigitalischaemiasuccessfullytreatedwithintravenousprostaglandine1
AT kagam caseofhypereosinophiliawithdigitalischaemiasuccessfullytreatedwithintravenousprostaglandine1
AT takeuchih caseofhypereosinophiliawithdigitalischaemiasuccessfullytreatedwithintravenousprostaglandine1
AT iwaharak caseofhypereosinophiliawithdigitalischaemiasuccessfullytreatedwithintravenousprostaglandine1
AT iharah caseofhypereosinophiliawithdigitalischaemiasuccessfullytreatedwithintravenousprostaglandine1

Ejemplares similares